Scarica l'app Stockscreener
9.96
4.18%
0.40
Pre-mercato:
10.00
0.04
+0.40%
Candel Therapeutics Inc Borsa (CADL) Ultime notizie
Candel Therapeutics Inc (CADL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
BlackRock (CADL holder) discloses 6.6% Candel Therapeutics stake on Schedule 13G - Stock Titan
CADL|Candel Therapeutics Inc|Price:9.560|Chg%:-0.300 - TradingKey
Candel Therapeutics Inc (CADL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Candel Therapeutics Inc (CADL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CADL Stock On Track For Best Day In Nearly 16 Months — What’s Driving The Rally? - Stocktwits
Candel Therapeutics Inc (CADL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Candel Therapeutics Inc (CADL) Balance Sheet - TradingKey
Candel Therapeutics Inc (CADL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Candel Therapeutics Inc (CADL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
ETFs Investing in Candel Therapeutics, Inc. Stocks - TradingView
Candel Therapeutics Insider Ups Holding By 14% During Year - simplywall.st
Candel Therapeutics (NASDAQ:CADL) Downgraded to Sell Rating by Wall Street Zen - MarketBeat
Candel Therapeutics Reported Better-Than-Feared Q1 Loss – But All Eyes Turn To This Pivotal Event Tomorrow - Stocktwits
Candel Therapeutics (NASDAQ:CADL) Shares Up 8.1%Here's Why - MarketBeat
CADL Stock Edges Up After Hours On Strong Extended Prostate Cancer Data - Stocktwits
Why CADL Stock Plunged Nearly 15% In After-Hours Trading Today - Stocktwits
Stifel Initiates Candel Therapeutics(CADL.US) With Buy Rating, Announces Target Price $22 - Moomoo
Liquidity Mapping Around (CADL) Price Events - Stock Traders Daily
CADL Initiates Coverage On Candel Therapeutics by Stifel -- Buy Rating Issued - GuruFocus
CADL Q1 2026 Earnings: Narrower Loss Per Share Surpasses Analyst Estimates Amid Ongoing Pipeline DevelopmentDebt Analysis Report - Bölüm Sonu Canavarı
Stifel initiates Candel Therapeutics stock with buy, $22 target By Investing.com - Investing.com Australia
Stifel initiates Candel Therapeutics stock with buy, $22 target - Investing.com UK
Candel Therapeutics (CADL) Short Interest & Short Float | Updated Jul 2026 - MarketBeat
Candel Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)July 8, 2026 - marketscreener.com
Form 4 Candel Therapeutics Inc For: 8 July By Investing.com - Investing.com Nigeria
[Form 4] Candel Therapeutics, Inc. Insider Trading Activity - Stock Titan
Candel Therapeutics (CADL) Chief Commercial Officer Sims listed in Form 3 - Stock Titan
Candel hands its new commercial chief 285,000 options - Stock Titan
Candel Therapeutics: An Overlooked Late-Stage Biotech With Real Potential - Seeking Alpha
Candel Therapeutics Q1 2026 Earnings: EPS Beats Estimates by 56.68% as Clinical Development AdvancesMargin Expansion Trends - dars.gov.et
Analysts Offer Insights on Healthcare Companies: Candel Therapeutics (CADL) and Ibio (IBIO) - The Globe and Mail
Why (CADL) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Insider Sell: Francesca Barone Sells Shares of Candel Therapeuti - GuruFocus
Candel Therapeutics CSO Francesca Barone sells $235k in stock By Investing.com - Investing.com Australia
Candel Therapeutics CSO Francesca Barone sells $235k in stock - Investing.com
Form 4 Candel Therapeutics Inc For: 1 July By Investing.com - Investing.com UK
Candel Therapeutics (CADL) CSO executes 23,447-share open-market sale under 10b5-1 plan - Stock Titan
Candel Therapeutics (CADL) CTO sells 7,000 shares in planned trade - Stock Titan
Candel Therapeutics (CADL) director receives fully vested grant of 2,199 stock options - Stock Titan
Candel Therapeutics (CADL) director receives fully vested option award - Stock Titan
1.97%
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):